Secondary amyloidosis risk factors: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Secondary amyloidosis}} {{CMG}} {{AE}} {{Sahar}} ==Overview== The most potent risk factor in the development of secondary amyloidosis is a persistent inflamm...")
 
No edit summary
Line 15: Line 15:
*** [[TNF Receptor associated periodic syndrome]] ([[TRAPS]])
*** [[TNF Receptor associated periodic syndrome]] ([[TRAPS]])
* [[Conditions]] associated with increased risk of secondary amyloidosis include:
* [[Conditions]] associated with increased risk of secondary amyloidosis include:
Chronic Infections
Tuberculosis
Leprosy
Whipple Disease
Osteomyelitis
Chronic pyelonephritis
Subacute bacterial endocarditis
Chronic cutaneous ulcers
Conditions Predisposing to Chronic Infections
Cystic fibrosis
Bronchiectasis
Kartagener syndrome
Epidermolysis bullosa
Injected drug abuse
Jejuno-ileal bypass
Paraplegia
Sickle cell anemia
Immunodeficiency
Common variable immunodeficiency
Cyclic neutropenia
Hyperimmunoglobulin M syndrome
Hypogammaglobulinemia
Sex-linked agammaglobulinemia
Human immunodeficiency virus/AIDS
Neoplasia
Adenocarcinoma
Basal cell carcinoma
Carcinoid tumor
Castleman disease
Gastrointestinal stromal tumor
Hairy cell leukemia
Hepatic adenoma
Hodgkin disease
Mesothelioma
Renal cell carcinoma
Sarcoma
Inflammatory Arthritis
Adult-onset Still disease
Ankylosing spondylitis
Juvenile idiopathic arthritis
Psoriatic arthropathy
Reiter syndrome
Rheumatoid arthritis
Gout
Systemic Vasculitis
Antineutrophil cytoplasmic antibody-associated vasculitis
Behc¸et disease
Giant cell arteritis
Polyarteritis nodosa
Polymyalgia rheumatica
Systemic lupus erythematosus
Takayasu arteritis
Periodic Fevers
Cryopyrin-associated periodic fever syndrome
Familial Mediterranean fever
Mevalonate kinase deficiency
Tumor necrosis factor receptor-associated periodic syndrome
Inflammatory Bowel Disease
Ulcerative colitis
Crohn diseases
Others
Atrial myxoma
Inflammatory abdominal aortic aneurism
Retroperitoneal fibrosis
SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome
Sarcoidosis
Sinus histiocytosis with massive lymphadenopathy

Revision as of 03:00, 30 October 2019

Secondary amyloidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Secondary amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Secondary amyloidosis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Secondary amyloidosis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Secondary amyloidosis risk factors

CDC on Secondary amyloidosis risk factors

Secondary amyloidosis risk factors in the news

Blogs on Secondary amyloidosis risk factors

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Secondary amyloidosis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Overview

The most potent risk factor in the development of secondary amyloidosis is a persistent inflammatory disorders.

Risk Factors

Chronic Infections Tuberculosis Leprosy Whipple Disease Osteomyelitis Chronic pyelonephritis Subacute bacterial endocarditis Chronic cutaneous ulcers Conditions Predisposing to Chronic Infections Cystic fibrosis Bronchiectasis Kartagener syndrome Epidermolysis bullosa Injected drug abuse Jejuno-ileal bypass Paraplegia Sickle cell anemia Immunodeficiency Common variable immunodeficiency Cyclic neutropenia Hyperimmunoglobulin M syndrome Hypogammaglobulinemia Sex-linked agammaglobulinemia Human immunodeficiency virus/AIDS Neoplasia Adenocarcinoma Basal cell carcinoma Carcinoid tumor Castleman disease Gastrointestinal stromal tumor Hairy cell leukemia Hepatic adenoma Hodgkin disease Mesothelioma Renal cell carcinoma Sarcoma Inflammatory Arthritis Adult-onset Still disease Ankylosing spondylitis Juvenile idiopathic arthritis Psoriatic arthropathy Reiter syndrome Rheumatoid arthritis Gout Systemic Vasculitis Antineutrophil cytoplasmic antibody-associated vasculitis Behc¸et disease Giant cell arteritis Polyarteritis nodosa Polymyalgia rheumatica Systemic lupus erythematosus Takayasu arteritis Periodic Fevers Cryopyrin-associated periodic fever syndrome Familial Mediterranean fever Mevalonate kinase deficiency Tumor necrosis factor receptor-associated periodic syndrome Inflammatory Bowel Disease Ulcerative colitis Crohn diseases Others Atrial myxoma Inflammatory abdominal aortic aneurism Retroperitoneal fibrosis SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome Sarcoidosis Sinus histiocytosis with massive lymphadenopathy

  1. Koivuniemi, Riitta; Paimela, Leena; Suomalainen, Risto; Törnroth, Tom; Leirisalo-Repo, Marjatta (2009). "Amyloidosis is frequently undetected in patients with rheumatoid arthritis". Amyloid. 15 (4): 262–268. doi:10.1080/13506120802524676. ISSN 1350-6129.
  2. Blank, Norbert; Hegenbart, Ute; Dietrich, Sascha; Brune, Maik; Beimler, Jörg; Röcken, Christoph; Müller-Tidow, Carsten; Lorenz, Hanns-Martin; Schönland, Stefan O. (2018). "Obesity is a significant susceptibility factor for idiopathic AA amyloidosis". Amyloid. 25 (1): 37–45. doi:10.1080/13506129.2018.1429391. ISSN 1350-6129.
  3. van der Hilst, J. C. H.; Yamada, T.; Op den Camp, H. J. M.; van der Meer, J. W. M.; Drenth, J. P. H.; Simon, A. (2008). "Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis". Rheumatology. 47 (11): 1651–1654. doi:10.1093/rheumatology/ken371. ISSN 1462-0324.
  4. Papa, Riccardo; Doglio, Matteo; Lachmann, Helen J.; Ozen, Seza; Frenkel, Joost; Simon, Anna; Neven, Bénédicte; Kuemmerle-Deschner, Jasmin; Ozgodan, Huri; Caorsi, Roberta; Federici, Silvia; Finetti, Martina; Trachana, Maria; Brunner, Jurgen; Bezrodnik, Liliana; Pinedo Gago, Mari Carmen; Maggio, Maria Cristina; Tsitsami, Elena; Al Suwairi, Wafaa; Espada, Graciela; Shcherbina, Anna; Aksu, Guzide; Ruperto, Nicolino; Martini, Alberto; Ceccherini, Isabella; Gattorno, Marco (2017). "A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry". Orphanet Journal of Rare Diseases. 12 (1). doi:10.1186/s13023-017-0720-3. ISSN 1750-1172.